A detailed history of Legal & General Group PLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Legal & General Group PLC holds 4,990,604 shares of TEVA stock, worth $110 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,990,604
Previous 4,990,604 -0.0%
Holding current value
$110 Million
Previous $89.9 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.81 - $18.96 $1.55 Million - $1.86 Million
98,277 Added 2.01%
4,990,604 $89.9 Million
Q2 2024

Aug 14, 2024

SELL
$12.78 - $17.4 $4.87 Million - $6.63 Million
-380,989 Reduced 7.22%
4,892,327 $79.5 Million
Q1 2024

May 14, 2024

SELL
$10.67 - $14.43 $824,161 - $1.11 Million
-77,241 Reduced 1.44%
5,273,316 $74.4 Million
Q4 2023

Feb 15, 2024

BUY
$8.12 - $10.63 $15 Million - $19.7 Million
1,850,033 Added 52.85%
5,350,557 $55.9 Million
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $30,914 - $44,223
4,133 Added 0.12%
3,500,524 $35.7 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $994,442 - $1.31 Million
138,117 Added 4.11%
3,496,391 $26.3 Million
Q1 2023

May 15, 2023

SELL
$8.36 - $11.37 $52.9 Million - $71.9 Million
-6,325,524 Reduced 65.32%
3,358,274 $29.7 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $12.2 Million - $14.6 Million
1,534,941 Added 18.84%
9,683,798 $88.3 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $866,411 - $1.51 Million
126,299 Added 1.57%
8,148,857 $65.8 Million
Q2 2022

Aug 22, 2022

SELL
$7.38 - $10.4 $1.62 Million - $2.29 Million
-219,828 Reduced 2.67%
8,022,558 $60.3 Million
Q1 2022

May 16, 2022

BUY
$7.33 - $9.39 $2.32 Million - $2.97 Million
316,017 Added 3.99%
8,242,386 $77.4 Million
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $6.69 Million - $8.63 Million
-847,309 Reduced 9.66%
7,926,369 $63.5 Million
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $377,234 - $458,262
45,016 Added 0.52%
8,773,678 $85.5 Million
Q2 2021

Aug 12, 2021

BUY
$9.9 - $11.56 $39.4 Million - $46 Million
3,980,002 Added 83.81%
8,728,662 $86.4 Million
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $25.4 Million - $31.5 Million
2,456,578 Added 107.18%
4,748,660 $54.8 Million
Q4 2020

Feb 12, 2021

SELL
$8.61 - $11.04 $5,346 - $6,855
-621 Reduced 0.03%
2,292,082 $22.1 Million
Q3 2020

Nov 13, 2020

SELL
$8.57 - $12.69 $2.25 Million - $3.33 Million
-262,187 Reduced 10.26%
2,292,703 $20.7 Million
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $663,184 - $1.07 Million
81,673 Added 3.3%
2,554,890 $31.5 Million
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $360,544 - $724,860
53,893 Added 2.23%
2,473,217 $22.2 Million
Q4 2019

Feb 13, 2020

BUY
$6.53 - $10.72 $946,412 - $1.55 Million
144,933 Added 6.37%
2,419,324 $23.7 Million
Q3 2019

Nov 13, 2019

BUY
$6.16 - $9.6 $1.01 Million - $1.58 Million
164,071 Added 7.77%
2,274,391 $15.6 Million
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $2.21 Million - $4.28 Million
272,515 Added 14.83%
2,110,320 $19.5 Million
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $17.6 Million - $22.6 Million
1,129,595 Added 159.5%
1,837,805 $28.8 Million
Q4 2018

Feb 15, 2019

BUY
$14.59 - $23.84 $1.72 Million - $2.81 Million
117,894 Added 19.97%
708,210 $10.9 Million
Q3 2018

Nov 20, 2018

SELL
$21.06 - $25.65 $7,834 - $9,541
-372 Reduced 0.06%
590,316 $12.7 Million
Q2 2018

Aug 10, 2018

SELL
$16.77 - $24.71 $356,043 - $524,618
-21,231 Reduced 3.47%
590,688 $14.4 Million
Q1 2018

May 17, 2018

BUY
$16.68 - $22.07 $1.3 Million - $1.72 Million
77,766 Added 14.56%
611,919 $10.5 Million
Q4 2017

Feb 13, 2018

BUY
$11.23 - $19.1 $6 Million - $10.2 Million
534,153
534,153 $10.1 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.